docetaxel anhydrous has been researched along with Jaundice, Cholestatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SY; Sundar, S | 1 |
| Arai, T; Fujimori, K; Gomyou, Y; Nakatsuji, Y; Okamoto, K; Shigeno, T; Shimizu, F; Suzuki, A; Tsuchiya, T | 1 |
2 other study(ies) available for docetaxel anhydrous and Jaundice, Cholestatic
| Article | Year |
|---|---|
Cholestatic jaundice and pseudomembranous colitis following combination therapy with doxorubicin and docetaxel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Docetaxel; Doxorubicin; Enterocolitis, Pseudomembranous; Female; Humans; Jaundice, Obstructive; Middle Aged; Taxoids | 2003 |
[A case of recurrent gastric cancer with obstructive jaundice successfully treated by docetaxel].
Topics: Adenocarcinoma; Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Gastrectomy; Humans; Jaundice, Obstructive; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Quality of Life; Stents; Stomach Neoplasms; Taxoids | 2007 |